Chemical Compound

1H-1-Ethyl Candesartan Cilexetil

CAS Registry Number 914613-35-7
1H-1-Ethyl Candesartan Cilexetil chemical structure
Primary Record

1H-1-Ethyl Candesartan Cilexetil

Note: Only for scientific research or as raw materials for production.

In stock
8,269 g
Purity
98.7 %
CAS
914613-35-7

Compound Identifiers & Properties

CAS
914613-35-7
PubChem CID
58852611
SMILES
CCN1C(=NN=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C5=C(C=CC=C5N=C4OCC)C(=O)OC(C)OC(=O)OC6CCCCC6
Canonical SMILES
CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnnn2CC)cc1

Names & Synonyms

  • 1H-1-Ethyl Candesartan Cilexetil
  • 914613-35-7
  • 1-Ethyl-Candesartan Cilexetil
  • RefChem:573710
  • Candesartan Cilexetil EP Impurity E
  • UNII-IN72J7R432
  • 1-N-ethyl 1,2,4-triazole
  • IN72J7R432
  • orb1306285
  • 1H-1-Ethyl-d5CandesartanCilexetil
  • Candesartan cilexetil impurity E [EP]
  • SCHEMBL14522914
  • SCHEMBL30007325
  • CANDESARTAN CILEXETIL IMPURITY E
  • CTK8E8170
  • Candesartan Cilexetil Impurity E
  • C35H38N6O6
  • DTXSID701101236
  • MFCD18382323
  • AKOS027323321
  • PD017566
  • TS-08172
  • DB-126878
  • HY-135180
  • RT-006595
  • CS-0109715
  • FT-0668191
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • G87495
  • A1-01751
  • CANDESARTAN CILEXETIL IMPURITY E [EP IMPURITY]
  • Q27280809
  • (+/-)-1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • (1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1-ethyl-1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
  • 1246819-47-5
  • 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
  • (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
  • (RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl-2-ethoxy-1-[[2 inverted exclamation mark -(1-ethyl-1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-benzimidazole-7-carboxylate
  • 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2 inverted exclamation marka-(1-ethyl-1H-tetrazol-5-yl)[1,1 inverted exclamation marka-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
  • 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2a(2)-(1-ethyl-1H-tetrazol-5-yl)[1,1a(2)-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
  • 110-945-1
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate; Candesartan Cilexetil Imp. E (EP); (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate; Candesartan Cilexetil Impurity E
  • 2-Ethoxy-1-[[2'-[1-ethyl-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester